TKR
The Timken Company
NYSEUSDEQUITY
Industrials
DELAYED
Last price
125.10
▲ 0.58 (0.47%)
MARKET · —
Price
Open
124.50
Prev close
124.52
Day high
126.87
Day low
124.14
Volume
484.20K
Market cap
$8.67B
P/E (TTM)
33.81
52W range
70.57 – 146.37
Trailing performance
Returnvs SPY
1W
-6.29%
-4.9%
1M
-11.21%
-14.9%
3M
+5.19%
+2.1%
6M
+15.66%
+4.6%
YTD
+48.70%
+36.4%
1Y
+64.91%
+44.9%
3Y
+65.15%
-9.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$8.67B
Enterprise value$10.64B
Revenue (TTM)$4.76B
Gross profit$1.47B
EBITDA$839.00M
Net income$258.70M
EPS (TTM)$3.70
Free cash flow$354.21M
Total cash$399.10M
Total debt$2.20B
Book value / share$46.03
Shares outstanding69.30M
Float66.61M
Short % of float4.55%
Dividend yield1.15%
Beta (5Y)1.23
Valuation & profitability ratios
Trailing P/E33.81
Forward P/E17.20
PEG ratio1.80
Price / sales—
Price / book2.72
EV / revenue2.24
EV / EBITDA12.68
Gross margin30.86%
Operating margin13.65%
Profit margin5.44%
Return on equity8.54%
Return on assets5.52%
Debt / equity65.52
Current ratio3.10
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $4.58B | $4.57B | $4.77B | $4.50B |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $288.40M | $352.70M | $394.10M | $407.40M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | $288.40M | $352.70M | $394.10M | $407.40M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 1.62 | 1.83 | +12.9% |
| Mar 2026 | 1.50 | 1.67 | +11.2% |
| Dec 2025 | 1.09 | 1.14 | +4.9% |
| Sep 2025 | 1.24 | 1.37 | +10.1% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 1.49 | 12 | $1.21B | +4.5% |
| Next quarter | 1.29 | 12 | $1.15B | +3.4% |
| Current year | 6.27 | 12 | $4.85B | +5.8% |
| Next year | 7.28 | 12 | $5.02B | +3.5% |
Analyst targets & ownership
Mean target$147.20
High target$160.00
Low target$129.00
Implied upside17.67%
Analyst count11
ConsensusBUY
Strong buy / Buy2 / 4
Hold6
Sell / Strong sell0 / 0
Held by insiders7.91%
Held by institutions97.32%
Institutions holding757
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
-19.21K
Net selling
Buy transactions
13
94.67K shares
Sell transactions
8
113.88K shares
Net transactions
+21
Buys less sells
Sell : buy shares
1.2 : 1
Mixed
Insider-held shares
5.48M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 10, 26 | KYLE RICHARD G Director |
SELL | 13.64K | $1.73M | Direct |
| Jun 5, 26 | RAJENDRA AJITA G Director |
SELL | 8.45K | $1.11M | Direct |
| May 27, 26 | KYLE RICHARD G Director |
SELL | 8.45K | $1.08M | Direct |
| May 18, 26 | KYLE RICHARD G Director |
STOCK | 646 | $0 | Direct |
| May 8, 26 | TIMKEN JOHN M JR Director |
SELL | 15.00K | $1.75M | Direct |
| May 8, 26 | KYLE RICHARD G Director |
SELL | 37.18K | $4.36M | Direct |
| May 1, 26 | LEOMBRUNO TODD M. Director |
STOCK | 2.27K | $0 | Direct |
| May 1, 26 | LAUBER SARAH C Director |
STOCK | 2.27K | $0 | Direct |
| May 1, 26 | HARRELL ELIZABETH ANN Director |
STOCK | 2.27K | $0 | Direct |
| May 1, 26 | CROWE MARIA A. Director |
STOCK | 2.27K | $0 | Direct |
| May 1, 26 | TIMKEN JOHN M JR Director |
STOCK | 2.27K | $0 | Direct |
| May 1, 26 | TIMKEN WARD JACKSON JR Director |
STOCK | 2.27K | $0 | Direct |
| May 1, 26 | MAPES CHRISTOPHER L Director |
STOCK | 2.27K | $0 | Direct |
| May 1, 26 | RYAN-DENNIS KIMBERLY K Director |
STOCK | 2.27K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
COUGHLIN CHRISTOPHER A |
Officer | 103.05K | Conversion of Exercise of derivative security |
CROWE MARIA A. |
Director | 29.94K | Stock Award(Grant) |
FRACASSA PHILIP D |
Chief Financial Officer | 101.48K | Sale |
KYLE RICHARD G |
Director | 183.72K | Sale |
MAPES CHRISTOPHER L |
Director | 30.59K | Stock Award(Grant) |
MEHTA TARAK |
Chief Executive Officer | 29.97K | Stock Award(Grant) |
ROELLGEN KARL ANDREAS |
Officer | 103.03K | Stock Award(Grant) |
SULLIVAN FRANK C |
Director | 69.47K | Stock Award(Grant) |
TIMKEN JOHN M JR |
Director | 768.55K | Sale |
TIMKEN WARD JACKSON JR |
Director | 714.95K | Stock Award(Grant) |
Moving averages & technicals
SMA 10
128.85
-2.91% from price
SMA 20
131.98
-5.21% from price
SMA 50
136.62
-8.43% from price
SMA 100
125.61
-0.40% from price
SMA 200
108.95
+14.82% from price
EMA 12
129.31
-3.25% from price
EMA 26
132.01
-5.23% from price
EMA 50
131.92
-5.17% from price
RSI (14)
38.5
Neutral
MACD (12,26,9)
-2.70
Hist -0.72
ATR (14)
4.50
3.60% of price
Realised vol 30D
37.6%
Annualised
Bollinger upper
142.03
20, 2σ
Bollinger lower
121.92
20, 2σ
50 / 200 cross
Golden
136.62 vs 108.95
Trend bias
Above 200
+14.82%
Risk profile
Beta vs SPY
1.45
More volatile than market
Correlation to SPY
0.55
Loosely linked
Realised vol 30D
37.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-14.3%
Peak to trough
Max drawdown 5Y
-38.9%
Peak to trough
ATR 14
4.50
3.60% of price
Beta (reported)
1.23
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
1.36
Put-heavy session
Put / call open interest
0.64
Positioning, not flow
Max pain
130.00
+3.9% from spot
ATM implied vol
40.2%
Nearest strike to spot
Skew (10% OTM)
-0.5%
Calls bid over puts
Call volume
180
Contracts, this expiry
Put volume
244
Contracts, this expiry
Heaviest call OI
135.00
226 contracts
Heaviest put OI
120.00
177 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Belden, Timken, ArcBest, Acuity Brands, and VSE Corporation Shares Plummet, What You Need To Know
StockStory · 4d ago
5 Insightful Analyst Questions From Timken’s Q2 Earnings Call
StockStory · 10d ago
3 Profitable Stocks We’re Skeptical Of
StockStory · 10d ago
Timken Insider Sold Shares Worth $1,726,853, According to a Recent SEC Filing
MT Newswires · 11d ago
Timken (TKR) Q2 2026 Earnings Call Transcript
Motley Fool · 11d ago
Is Gates Stock Worth Buying as Growth Improves but Risks Persist?
Zacks · 12d ago
Timken (TKR) Is Down 8.1% After Raising 2026 Outlook And Reshaping Leadership Team
Simply Wall St. · 12d ago
Why Is Timken (TKR) Getting Fresh Attention Now?
Simply Wall St. · 12d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.